148 related articles for article (PubMed ID: 37068931)
1. Disability accrual in primary and secondary progressive multiple sclerosis.
Harding-Forrester S; Roos I; Nguyen AL; Malpas CB; Diouf I; Moradi N; Sharmin S; Izquierdo G; Eichau S; Patti F; Horakova D; Kubala Havrdova E; Prat A; Girard M; Duquette P; Grand'Maison F; Onofrj M; Lugaresi A; Grammond P; Ozakbas S; Amato MP; Gerlach O; Sola P; Ferraro D; Buzzard K; Skibina O; Lechner-Scott J; Alroughani R; Boz C; Van Pesch V; Cartechini E; Terzi M; Maimone D; Ramo-Tello C; Yamout B; Khoury SJ; La Spitaleri D; Sa MJ; Blanco Y; Granella F; Slee M; Butler E; Sidhom Y; Gouider R; Bergamaschi R; Karabudak R; Ampapa R; Sánchez-Menoyo JL; Prevost J; Castillo-Trivino T; McCombe PA; Macdonell R; Laureys G; Van Hijfte L; Oh J; Altintas A; de Gans K; Turkoglu R; van der Walt A; Butzkueven H; Vucic S; Barnett M; Cristiano E; Hodgkinson S; Iuliano G; Kappos L; Kuhle J; Shaygannejad V; Soysal A; Weinstock-Guttman B; Van Wijmeersch B; Kalincik T;
J Neurol Neurosurg Psychiatry; 2023 Sep; 94(9):707-717. PubMed ID: 37068931
[TBL] [Abstract][Full Text] [Related]
2. Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
Leppert D; Kropshofer H; Häring DA; Dahlke F; Patil A; Meinert R; Tomic D; Kappos L; Kuhle J
Neurology; 2022 May; 98(21):e2120-e2131. PubMed ID: 35379762
[TBL] [Abstract][Full Text] [Related]
3. Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis.
Naegelin Y; Naegelin P; von Felten S; Lorscheider J; Sonder J; Uitdehaag BMJ; Scotti B; Zecca C; Gobbi C; Kappos L; Derfuss T
JAMA Neurol; 2019 Mar; 76(3):274-281. PubMed ID: 30615019
[TBL] [Abstract][Full Text] [Related]
4. Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis.
Hughes J; Jokubaitis V; Lugaresi A; Hupperts R; Izquierdo G; Prat A; Girard M; Duquette P; Grand'Maison F; Grammond P; Sola P; Ferraro D; Ramo-Tello C; Trojano M; Slee M; Shaygannejad V; Boz C; Lechner-Scott J; Van Pesch V; Pucci E; Solaro C; Verheul F; Terzi M; Granella F; Spitaleri D; Alroughani R; Jun JK; Fambiatos A; Van der Walt A; Butzkueven H; Kalincik T;
JAMA Neurol; 2018 Nov; 75(11):1407-1415. PubMed ID: 30083762
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity on long-term disability trajectories in patients with secondary progressive MS: a latent class analysis from Big MS Data network.
Signori A; Lorscheider J; Vukusic S; Trojano M; Iaffaldano P; Hillert J; Hyde R; Pellegrini F; Magyari M; Koch-Henriksen N; Sørensen PS; Spelman T; van der Walt A; Horakova D; Havrdova E; Girard M; Eichau S; Grand'Maison F; Gerlach O; Terzi M; Ozakbas S; Skibina O; Van Pesch V; Sa MJ; Prevost J; Alroughani R; McCombe PA; Gouider R; Mrabet S; Castillo-Trivino T; Zhu C; de Gans K; Sánchez-Menoyo JL; Yamout B; Khoury S; Sormani MP; Kalincik T; Butzkueven H;
J Neurol Neurosurg Psychiatry; 2023 Jan; 94(1):23-30. PubMed ID: 36171104
[TBL] [Abstract][Full Text] [Related]
6. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities.
Tremlett H; Zhao Y; Devonshire V;
J Neurol; 2009 Mar; 256(3):374-81. PubMed ID: 19308306
[TBL] [Abstract][Full Text] [Related]
7. Association of Sustained Immunotherapy With Disability Outcomes in Patients With Active Secondary Progressive Multiple Sclerosis.
Lizak N; Malpas CB; Sharmin S; Havrdova EK; Horakova D; Izquierdo G; Eichau S; Lugaresi A; Duquette P; Girard M; Prat A; Larochelle C; Trojano M; Grand'Maison F; Grammond P; Sola P; Ferraro D; Hupperts R; Bergamaschi R; Boz C; Van Pesch V; Spitaleri D; Terzi M; Kalincik T;
JAMA Neurol; 2020 Nov; 77(11):1398-1407. PubMed ID: 32716480
[TBL] [Abstract][Full Text] [Related]
8. Clinical predictors of disease progression in a cohort of Tunisian progressive Multiple Sclerosis.
Souissi A; Mrabet S; Nasri A; Ben Djebara M; Gargouri A; Kacem I; Gouider R
Mult Scler Relat Disord; 2021 Nov; 56():103232. PubMed ID: 34619488
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis by phenotype in Germany.
Engelhard J; Oleske DM; Schmitting S; Wells KE; Talapala S; Barbato LM
Mult Scler Relat Disord; 2022 Jan; 57():103326. PubMed ID: 35158442
[TBL] [Abstract][Full Text] [Related]
10. Risk of secondary progressive multiple sclerosis after early worsening of disability.
Dzau W; Sharmin S; Patti F; Izquierdo G; Eichau S; Prat A; Girard M; Duquette P; Onofrj M; Lugaresi A; Ozakbas S; Gerlach O; Boz C; Grammond P; Terzi M; Amato MP; La Spitaleri D; Ramo-Tello C; Maimone D; Cartechini E; Buzzard K; Skibina O; van der Walt A; Butzkueven H; Iuliano G; Soysal A; Kalincik T
J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):984-991. PubMed ID: 37414538
[TBL] [Abstract][Full Text] [Related]
11. Intravenous immunoglobulin in primary and secondary chronic progressive multiple sclerosis: a randomized placebo controlled multicentre study.
Pöhlau D; Przuntek H; Sailer M; Bethke F; Koehler J; König N; Heesen C; Späth P; Andresen I
Mult Scler; 2007 Nov; 13(9):1107-17. PubMed ID: 17623736
[TBL] [Abstract][Full Text] [Related]
12. Comparison of disease activity in SPMS and PPMS in the context of multicenter clinical trials.
Orbach R; Zhao Z; Wang YC; O'Neill G; Cadavid D
PLoS One; 2012; 7(10):e45409. PubMed ID: 23049678
[TBL] [Abstract][Full Text] [Related]
13. Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study.
Blinkenberg M; Kjellberg J; Ibsen R; Magyari M
Mult Scler Relat Disord; 2020 Nov; 46():102567. PubMed ID: 33296969
[TBL] [Abstract][Full Text] [Related]
14. Onset of progressive phase is an age-dependent clinical milestone in multiple sclerosis.
Tutuncu M; Tang J; Zeid NA; Kale N; Crusan DJ; Atkinson EJ; Siva A; Pittock SJ; Pirko I; Keegan BM; Lucchinetti CF; Noseworthy JH; Rodriguez M; Weinshenker BG; Kantarci OH
Mult Scler; 2013 Feb; 19(2):188-98. PubMed ID: 22736750
[TBL] [Abstract][Full Text] [Related]
15. The natural history of early versus late disability accumulation in primary progressive MS.
Koch MW; Greenfield J; Javizian O; Deighton S; Wall W; Metz LM
J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):615-21. PubMed ID: 25091366
[TBL] [Abstract][Full Text] [Related]
16. Rehabilitation with neuromuscular electrical stimulation leads to functional gains in ambulation in patients with secondary progressive and primary progressive multiple sclerosis: a case series report.
Wahls TL; Reese D; Kaplan D; Darling WG
J Altern Complement Med; 2010 Dec; 16(12):1343-9. PubMed ID: 21138391
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory disease-modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study.
Lorscheider J; Kuhle J; Izquierdo G; Lugaresi A; Havrdova E; Horakova D; Hupperts R; Duquette P; Girard M; Prat A; Grand'Maison F; Grammond P; Sola P; Ferraro D; Trojano M; Ramo-Tello C; Lechner-Scott J; Pucci E; Solaro C; Slee M; Van Pesch V; Sanchez Menoyo JL; van der Walt A; Butzkueven H; Kappos L; Kalincik T;
Eur J Neurol; 2019 Feb; 26(2):363-370. PubMed ID: 30298572
[TBL] [Abstract][Full Text] [Related]
18. Multiple Sclerosis Progressive Courses: A Clinical Cohort Long-Term Disability Progression Study.
Cortesi PA; Fornari C; Capra R; Cozzolino P; Patti F; Mantovani LG
Value Health; 2022 Sep; 25(9):1489-1498. PubMed ID: 35484029
[TBL] [Abstract][Full Text] [Related]
19. Natural history of secondary-progressive multiple sclerosis.
Tremlett H; Yinshan Zhao ; Devonshire V
Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.
Lorscheider J; Jokubaitis VG; Spelman T; Izquierdo G; Lugaresi A; Havrdova E; Horakova D; Trojano M; Duquette P; Girard M; Prat A; Grand'Maison F; Grammond P; Pucci E; Boz C; Sola P; Ferraro D; Spitaleri D; Lechner-Scott J; Terzi M; Van Pesch V; Iuliano G; Bergamaschi R; Ramo-Tello C; Granella F; Oreja-Guevara C; Butzkueven H; Kalincik T;
Neurology; 2017 Sep; 89(10):1050-1059. PubMed ID: 28794248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]